Search

everythinglearnresearchcommunity

for

Search:↓

Topical latanoprost and bimatoprost ophthalmic solutions don't help eyelash growth in patients with alopecia areata.

GI197111X is best dissolved in Capmul MCM for trials.

These new skin treatments are safer and more effective with minimal side effects.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Topical tacrolimus can effectively treat erosive pustular dermatosis and related hair loss.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Botanical lotion CG428 may help regrow hair and reduce scalp inflammation in chemotherapy patients.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Early diagnosis and strong corticosteroids are crucial for managing lymphocytic cicatricial alopecia.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

A 21-year-old with lichen planopilaris was successfully treated, stopping disease progression and preventing crusts.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Baricitinib is effective and safe for treating severe alopecia areata.

A CCS patient with severe complications was successfully treated using combined therapies.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Latanoprost eye drops may cause skin depigmentation.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Topical 1% pimecrolimus effectively treated alopecia areata.